What are the benefits of the HMOs 2FL and LNnT when added to infant formulae?

Formulae with 2’FL and LNnT offer a significant advantage in comparison to formulae without HMOs, with initial results of clinical studies being promising. Some of the key advantages are:

• Improved Immunity
• Gut microbiota is closer to the microbiota observed in breastfed infants, both in terms of composition and metabolic activity
• Stool microbiota in term infants is associated with reduced likelihood of medication (antibiotics)
• Lower incidence of bronchitis, lower respiratory infections, and reduced use of antipyretics and antibiotics
• Normal growth similar to breastfed infants
• Digestive tolerance similar to formula without 2’FL and LNnT, with softer stool conistency